Splash Beverage Group Gains NYSE American Plan Approval, Extends Listing to Jan 2027
SBEV•Splash Beverage Group secured NYSE American acceptance of its compliance plan, extending its listing deadline to January 29, 2027 and establishing a framework for its strategic transformation. It strengthened liquidity via an equity line facility, invested in Avicanna and acquired exclusive global rights to CannEpil epilepsy therapy.
1. NYSE American Compliance Plan Acceptance
Splash Beverage Group secured acceptance of its compliance plan by NYSE American, granting the company until January 29, 2027 to meet listing standards and continue trading while executing its turnaround strategy.
2. Strengthening Liquidity via Equity Line Facility
The company activated its equity line facility to bolster liquidity, aiming to resolve legacy obligations, satisfy vendor claims and improve its balance sheet ahead of the compliance deadline.
3. Strategic Investments and Licensing Acquisitions
Within 60 days of plan submission, Splash invested in cannabinoid firm Avicanna and acquired exclusive global licensing rights to CannEpil epilepsy therapy, advancing its transformation into a cannabinoid wellness and biopharmaceutical platform.
